|
US5516931A
(en)
|
1982-02-01 |
1996-05-14 |
Northeastern University |
Release tag compounds producing ketone signal groups
|
|
US4650750A
(en)
|
1982-02-01 |
1987-03-17 |
Giese Roger W |
Method of chemical analysis employing molecular release tag compounds
|
|
US4709016A
(en)
|
1982-02-01 |
1987-11-24 |
Northeastern University |
Molecular analytical release tags and their use in chemical analysis
|
|
US5650270A
(en)
|
1982-02-01 |
1997-07-22 |
Northeastern University |
Molecular analytical release tags and their use in chemical analysis
|
|
EP0407342A3
(en)
|
1989-07-06 |
1991-07-10 |
Ciba-Geigy Ag |
Pyrimidine derivatives
|
|
DE3922392A1
(de)
|
1989-07-07 |
1991-01-17 |
Merck Patent Gmbh |
Chromanderivate
|
|
US5470975A
(en)
|
1990-10-16 |
1995-11-28 |
E.R. Squibb & Sons, Inc. |
Dihydropyrimidine derivatives
|
|
US5374615A
(en)
|
1990-10-31 |
1994-12-20 |
E. R. Squibb & Sons, Inc. |
Indole- and benzimidazole-substituted imidazole and benzimidazole derivatives
|
|
PH31175A
(en)
|
1990-10-31 |
1998-03-20 |
Squibb & Sons Inc |
Indole and benzimi-dazole-substituted imidazole and benzimidazole derivatives.
|
|
DE4221583A1
(de)
|
1991-11-12 |
1993-05-13 |
Bayer Ag |
Substituierte biphenylpyridone
|
|
US5234923A
(en)
|
1991-12-16 |
1993-08-10 |
E. R. Squibb & Sons, Inc. |
Substitute indole and benzimidazole derivatives
|
|
US5378720A
(en)
|
1991-12-19 |
1995-01-03 |
Sterling Winthrop Inc. |
Saccharin derivative proteolytic enzyme inhibitors
|
|
GB2263639A
(en)
|
1992-01-28 |
1993-08-04 |
Merck & Co Inc |
Substituted pyrimidinones as neurotensin antagonists
|
|
US5510362A
(en)
|
1992-03-13 |
1996-04-23 |
Merck, Sharp And Dohme Limited |
Imidazole, triazole and tetrazole derivatives
|
|
GB9207396D0
(en)
|
1992-04-03 |
1992-05-13 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
US5294722A
(en)
|
1992-04-16 |
1994-03-15 |
E. R. Squibb & Sons, Inc. |
Process for the preparation of imidazoles useful in angiotensin II antagonism
|
|
DE4316077A1
(de)
|
1993-05-13 |
1994-11-17 |
Bayer Ag |
Substituierte Mono- und Bihydridylmethylpyridone
|
|
US5512576A
(en)
|
1994-12-02 |
1996-04-30 |
Sterling Winthrop Inc. |
2-substituted 1,2,5,-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof
|
|
TW324008B
(en)
|
1995-03-13 |
1998-01-01 |
Ishihara Sangyo Kaisha |
Pyridone sulfonylurea compound, its production process and weed killer containing such compound
|
|
EP1076655A1
(en)
|
1998-04-08 |
2001-02-21 |
Novartis AG |
N-pyridonyl herbicides
|
|
DE19826671A1
(de)
|
1998-06-16 |
1999-12-23 |
Hoechst Schering Agrevo Gmbh |
1,3-Oxazolin- und 1,3-Thiazolin-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Schädlingsbekämpfungsmittel
|
|
OA12118A
(en)
|
1999-12-10 |
2006-05-04 |
Pfizer Prod Inc |
PyrroloÄ2,3-dÜpyrimidine compounds.
|
|
WO2001096308A1
(en)
|
2000-06-12 |
2001-12-20 |
Eisai Co., Ltd. |
1,2-dihydropyridine compounds, process for preparation of the same and use thereof
|
|
PE20020354A1
(es)
|
2000-09-01 |
2002-06-12 |
Novartis Ag |
Compuestos de hidroxamato como inhibidores de histona-desacetilasa (hda)
|
|
US7348334B2
(en)
|
2001-04-09 |
2008-03-25 |
Dr. Reddy's Laboratories Limited |
Monocyclic derivatives of aryl alkanoic acids and their use in medicine: process for their preparation and pharmaceutical compositions containing them
|
|
WO2002081454A1
(en)
|
2001-04-09 |
2002-10-17 |
Dr. Reddy's Laboratories Ltd. |
Derivatives of aryl acids, their use in medicine, process for their preparation and pharmaceutical compositions containing them
|
|
KR100833371B1
(ko)
|
2001-04-27 |
2008-05-28 |
젠야쿠코교가부시키가이샤 |
헤테로시클릭 화합물 및 이를 유효 성분으로 하는 항종양제
|
|
US6642390B2
(en)
|
2001-07-11 |
2003-11-04 |
Lexicon Pharmaceuticals, Inc. |
One step synthesis of 1,2,3-triazole carboxylic acids
|
|
CA2462289C
(en)
|
2001-10-04 |
2010-02-23 |
Nicholas D. Cosford |
Heteroaryl substituted tetrazole modulators of metabotropic glutamate receptor-5
|
|
GB0129260D0
(en)
|
2001-12-06 |
2002-01-23 |
Eisai London Res Lab Ltd |
Pharmaceutical compositions and their uses
|
|
JP4286146B2
(ja)
|
2001-12-18 |
2009-06-24 |
メルク エンド カムパニー インコーポレーテッド |
メタボトロピックグルタミン酸受容体−5のヘテロアリール置換ピラゾール系調節剤
|
|
EP1458708B1
(en)
|
2001-12-18 |
2007-09-26 |
Merck & Co., Inc. |
Heteroaryl substituted triazole modulators of metabotropic glutamate receptor-5
|
|
EP1458385A4
(en)
|
2001-12-19 |
2005-12-21 |
Merck & Co Inc |
METABOTROPIC GLUTAMATE RECEPTOR 5-HETEROARYL-SUBSTITUTED IMIDAZOLE MODULATORS
|
|
JP4357965B2
(ja)
|
2001-12-21 |
2009-11-04 |
メルク エンド カムパニー インコーポレーテッド |
メタボトロピックグルタミン酸受容体−5のヘテロアリール置換ピロールモジュレーター
|
|
TWI329105B
(en)
|
2002-02-01 |
2010-08-21 |
Rigel Pharmaceuticals Inc |
2,4-pyrimidinediamine compounds and their uses
|
|
AP1822A
(en)
|
2002-02-14 |
2008-01-30 |
Pharmacia Corp |
Substituted pyridinones as modulators of P38 MAP kinase.
|
|
EP1358868A3
(fr)
|
2002-04-23 |
2003-11-19 |
L'oreal |
Composition cosmétique pour favoriser la pousse et/ou empecher ou retarder la chute des cheveux
|
|
MXPA05001766A
(es)
|
2002-08-14 |
2005-08-19 |
Atugen Ag |
Uso de proteina quinasa n beta.
|
|
WO2004030637A2
(en)
|
2002-10-01 |
2004-04-15 |
Merck & Co., Inc. |
Treatment of obesity and other disorders associated with excessive food intake
|
|
CN1735601A
(zh)
|
2002-11-08 |
2006-02-15 |
先灵公司 |
抑制整联蛋白与其受体结合的羧酸衍生物和其它治疗化合物的组合产物
|
|
US7332508B2
(en)
|
2002-12-18 |
2008-02-19 |
Novo Nordisk A/S |
Substituted homopiperidine, piperidine or pyrrolidine derivatives
|
|
US20070167621A1
(en)
|
2003-04-03 |
2007-07-19 |
Pharmacia Corporation |
Substituted pyrimidinones
|
|
WO2004089925A1
(en)
|
2003-04-03 |
2004-10-21 |
Semafore Pharmaceuticals, Inc. |
Pi-3 kinase inhibitor prodrugs
|
|
US7183287B2
(en)
|
2003-04-03 |
2007-02-27 |
Pharmacia Corporation |
Substituted pyrimidinones
|
|
CN100537564C
(zh)
|
2003-04-04 |
2009-09-09 |
麦克公司 |
代谢型谷氨酸受体-5的二芳基取代三唑调节剂
|
|
ES2382377T3
(es)
|
2003-05-30 |
2012-06-07 |
Gemin X Pharmaceuticals Canada Inc. |
Compuestos triheterocíclicos, composiciones, y métodos para tratar cáncer
|
|
WO2005007623A2
(en)
|
2003-07-03 |
2005-01-27 |
The Trustees Of The University Of Pennsylvania |
Inhibition of syk kinase expression
|
|
CL2004002050A1
(es)
|
2003-08-13 |
2005-06-03 |
Pharmacia Corp Sa Organizada B |
Compuestos derivados de piridinonas sustituidas; su uso en el tratamiento de afecciones causadas o exacerbadas por actividad p38 map kinasa y/o tnf no regulada, tales como inflamaciones, tumores, sida y otros.
|
|
CA2538960C
(en)
|
2003-09-17 |
2013-03-19 |
Sumitomo Chemical Company, Limited |
Cinnamoyl compound and use of the same
|
|
US7319108B2
(en)
|
2004-01-25 |
2008-01-15 |
Sanofi-Aventis Deutschland Gmbh |
Aryl-substituted heterocycles, process for their preparation and their use as medicaments
|
|
DE102004003812A1
(de)
|
2004-01-25 |
2005-08-11 |
Aventis Pharma Deutschland Gmbh |
Arylsubstituierte Heterozyklen, Verfahren ihrer Herstellung und ihre Verwendung als Arzneimittel
|
|
LT2612862T
(lt)
|
2004-05-13 |
2017-01-25 |
Icos Corporation |
Chinazolinonai kaip žmogaus fosfatidilinozitol-3-kinazės delta inhibitoriai
|
|
GB0420722D0
(en)
|
2004-09-17 |
2004-10-20 |
Addex Pharmaceuticals Sa |
Novel allosteric modulators
|
|
TWI309240B
(en)
|
2004-09-17 |
2009-05-01 |
Hoffmann La Roche |
Anti-ox40l antibodies
|
|
DE102004058449A1
(de)
|
2004-12-03 |
2006-06-14 |
Merck Patent Gmbh |
Tetrahydropyranderivate
|
|
US7449458B2
(en)
|
2005-01-19 |
2008-11-11 |
Rigel Pharmaceuticals, Inc. |
Prodrugs of 2,4-pyrimidinediamine compounds and their uses
|
|
JP5238936B2
(ja)
|
2005-03-25 |
2013-07-17 |
ジーアイティーアール,インク. |
Gitr結合分子およびその使用
|
|
ES2493466T3
(es)
|
2005-05-12 |
2014-09-11 |
Abbvie Bahamas Ltd. |
Promotores de la apoptosis
|
|
GB0510390D0
(en)
|
2005-05-20 |
2005-06-29 |
Novartis Ag |
Organic compounds
|
|
US8017635B2
(en)
|
2005-06-02 |
2011-09-13 |
Fmc Corporation |
Phenylalkyl substituted heteroaryl derivatives
|
|
AU2006255084A1
(en)
|
2005-06-08 |
2006-12-14 |
Novartis Ag |
Organic compounds
|
|
KR101704734B1
(ko)
|
2005-07-01 |
2017-02-09 |
이. 알. 스퀴부 앤드 선즈, 엘.엘.씨. |
예정 사멸 리간드 1 (피디-엘1)에 대한 인간 모노클로날 항체
|
|
TW200740755A
(en)
|
2005-07-13 |
2007-11-01 |
Bayer Cropscience Sa |
Dihalogenation of N,O-disubstituted hydroxypyridones and their uses
|
|
US7402325B2
(en)
|
2005-07-28 |
2008-07-22 |
Phoenix Biotechnology, Inc. |
Supercritical carbon dioxide extract of pharmacologically active components from Nerium oleander
|
|
US20080280949A1
(en)
|
2005-08-11 |
2008-11-13 |
Astrazeneca Ab |
Oxopyridyl Quinoline Amides as Nk3 Receptor Modulators
|
|
CA2621144A1
(en)
|
2005-09-02 |
2007-03-08 |
Arena Pharmaceuticals, Inc. |
Human g protein-coupled receptor and modulators thereof for the treatment of atherosclerosis and atherosclerotic disease and for the treatment of conditions related to mcp-1 expression
|
|
HRP20140975T1
(hr)
|
2005-10-07 |
2014-11-21 |
Exelixis, Inc. |
Derivati n-(3-amino-hinoksalin-2-il)-sulfonamida i njihova uporaba kao inhibitora fosfatidilinozitol 3-kinaze
|
|
US7973060B2
(en)
|
2005-10-13 |
2011-07-05 |
Crystalgenomics, Inc. |
Fab I inhibitor and process for preparing same
|
|
WO2007053452A1
(en)
|
2005-11-01 |
2007-05-10 |
Targegen, Inc. |
Bi-aryl meta-pyrimidine inhibitors of kinases
|
|
EA200801414A1
(ru)
|
2005-11-22 |
2008-10-30 |
Смитклайн Бичам Корпорейшн |
Кальцилитические соединения
|
|
US7728017B2
(en)
|
2005-11-30 |
2010-06-01 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of c-Met and uses thereof
|
|
HUE028588T2
(hu)
|
2005-12-13 |
2016-12-28 |
Incyte Holdings Corp |
Heteroaril-szubsztituált pirrolo[2,3-b]piridinek és pirrolo[2,3-b]pirimidinek mint Janus-kináz inhibitorok
|
|
JO2660B1
(en)
|
2006-01-20 |
2012-06-17 |
نوفارتيس ايه جي |
Pi-3 inhibitors and methods of use
|
|
JP2009523845A
(ja)
|
2006-01-23 |
2009-06-25 |
クリスタルゲノミクス インコーポレーテッド |
たんぱく質キナーゼの活性を阻害するイミダゾピリジン誘導体、これの製造方法およびこれを含む薬学組成物
|
|
EP1987022A1
(en)
|
2006-02-10 |
2008-11-05 |
Pfizer Products Inc. |
Pyridinone pyrazole urea and pyrimidinone pyrazole urea derivatives
|
|
AR059898A1
(es)
|
2006-03-15 |
2008-05-07 |
Janssen Pharmaceutica Nv |
Derivados de 3-ciano-piridona 1,4-disustituida y su uso como moduladores alostericos de los receptores mglur2
|
|
KR101533461B1
(ko)
|
2006-04-26 |
2015-07-02 |
에프. 호프만-라 로슈 아게 |
Pi3k저해제로 유용한 티에노[3,2-d]피리미딘 유도체
|
|
JP2007308402A
(ja)
|
2006-05-17 |
2007-11-29 |
Sumitomo Chemical Co Ltd |
シンナモイル化合物及びその用途
|
|
JP2007308441A
(ja)
|
2006-05-22 |
2007-11-29 |
Sumitomo Chemical Co Ltd |
含複素環化合物及びその用途
|
|
DE602007010287D1
(de)
*
|
2006-06-05 |
2010-12-16 |
Novartis Ag |
Organische verbindungen
|
|
US7932390B2
(en)
|
2006-06-29 |
2011-04-26 |
Hoffman-La Roche Inc. |
Substituted thieno[3,2-C]pyridine carboxylic acid derivatives
|
|
WO2008025886A1
(en)
|
2006-09-01 |
2008-03-06 |
Wallac Oy |
Metal chelates and chelating agents containing triazolyl subunits
|
|
WO2008030408A2
(en)
|
2006-09-05 |
2008-03-13 |
Yale University |
Proteomimetic compounds as inhibitors of the interaction of a nuclear receptor with coactivator peptides
|
|
EP2529621B1
(en)
|
2006-09-22 |
2016-10-05 |
Pharmacyclics LLC |
Inhibitors of bruton's tyrosine kinase
|
|
WO2008064318A2
(en)
|
2006-11-22 |
2008-05-29 |
University Of Medicine And Dentistry Of New Jersey |
Peripheral opioid receptor active compounds
|
|
WO2008064317A1
(en)
|
2006-11-22 |
2008-05-29 |
University Of Medicine And Dentistry Of New Jersey |
Lipophilic opioid receptor active compounds
|
|
WO2008143649A2
(en)
|
2006-12-04 |
2008-11-27 |
Dr. Reddy's Laboratories Limited |
Novel oxazolidinone compounds as antiinfective agents
|
|
AR065622A1
(es)
|
2007-03-07 |
2009-06-17 |
Ortho Mcneil Janssen Pharm |
Derivados de 3-ciano -4- (4-fenil- piperidin -1- il) piridin -2- ona
|
|
TW200845978A
(en)
|
2007-03-07 |
2008-12-01 |
Janssen Pharmaceutica Nv |
3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
|
|
TW200900065A
(en)
|
2007-03-07 |
2009-01-01 |
Janssen Pharmaceutica Nv |
3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
|
|
HUE029188T2
(en)
|
2007-03-12 |
2017-03-28 |
Ym Biosciences Australia Pty |
Phenylamino-pyrimidine compounds and their use
|
|
US8394794B2
(en)
|
2007-03-23 |
2013-03-12 |
Regents Of The University Of Minnesota |
Therapeutic compounds
|
|
TWI448284B
(zh)
|
2007-04-24 |
2014-08-11 |
Theravance Inc |
雙效抗高血壓劑
|
|
EP1987839A1
(en)
|
2007-04-30 |
2008-11-05 |
I.N.S.E.R.M. Institut National de la Sante et de la Recherche Medicale |
Cytotoxic anti-LAG-3 monoclonal antibody and its use in the treatment or prevention of organ transplant rejection and autoimmune disease
|
|
PE20090717A1
(es)
|
2007-05-18 |
2009-07-18 |
Smithkline Beecham Corp |
Derivados de quinolina como inhibidores de la pi3 quinasa
|
|
WO2008156580A1
(en)
|
2007-06-13 |
2008-12-24 |
Merck & Co., Inc. |
Triazole derivatives for treating alzheimer's disease and related conditions
|
|
PT2175884T
(pt)
|
2007-07-12 |
2016-09-21 |
Gitr Inc |
Terapias de combinação empregando moléculas de ligação a gitr
|
|
CA2695304A1
(en)
*
|
2007-08-02 |
2009-02-05 |
Pfizer Inc. |
Pyrimidine and pyridine derivatives and their pharmaceutical use and compositions
|
|
CN101848897A
(zh)
|
2007-09-06 |
2010-09-29 |
先灵公司 |
γ分泌酶调节剂
|
|
EA017648B1
(ru)
|
2007-09-14 |
2013-02-28 |
Орто-Макнейл-Янссен Фармасьютикалз, Инк. |
1',3'-двузамещенные-4-фенил-3,4,5,6-тетрагидро-2н,1'н-[1,4']бипириди-нил-2'-оны
|
|
EP2044949A1
(en)
|
2007-10-05 |
2009-04-08 |
Immutep |
Use of recombinant lag-3 or the derivatives thereof for eliciting monocyte immune response
|
|
WO2009073620A2
(en)
|
2007-11-30 |
2009-06-11 |
Newlink Genetics |
Ido inhibitors
|
|
JP2009161479A
(ja)
|
2008-01-07 |
2009-07-23 |
Sumitomo Chemical Co Ltd |
含複素環化合物及びその用途
|
|
MY165582A
(en)
|
2008-03-11 |
2018-04-05 |
Incyte Holdings Corp |
Azetidine and cyclobutane derivatives as jak inhibitors
|
|
UA105362C2
(en)
|
2008-04-02 |
2014-05-12 |
Бьорингер Ингельхайм Интернациональ Гмбх |
1-heterocyclyl-1, 5-dihydro-pyrazolo [3, 4-d] pyrimidin-4-one derivatives and their use as pde9a modulators
|
|
PE20091953A1
(es)
|
2008-05-08 |
2010-01-09 |
Du Pont |
Azoles sustituidos como fungicidas
|
|
EP2296789A1
(fr)
|
2008-05-29 |
2011-03-23 |
Saint-Gobain Centre de Recherches et d'Etudes Européen |
Structure en nid d'abeille a base de titanate d'aluminium
|
|
US8338439B2
(en)
|
2008-06-27 |
2012-12-25 |
Celgene Avilomics Research, Inc. |
2,4-disubstituted pyrimidines useful as kinase inhibitors
|
|
AR072999A1
(es)
|
2008-08-11 |
2010-10-06 |
Medarex Inc |
Anticuerpos humanos que se unen al gen 3 de activacion linfocitaria (lag-3) y los usos de estos
|
|
US9643922B2
(en)
|
2008-08-18 |
2017-05-09 |
Yale University |
MIF modulators
|
|
MX2011001872A
(es)
|
2008-08-18 |
2011-05-23 |
Univ Yale |
Moduladores de mif.
|
|
US9540322B2
(en)
|
2008-08-18 |
2017-01-10 |
Yale University |
MIF modulators
|
|
MX356367B
(es)
|
2008-12-09 |
2018-05-25 |
Genentech Inc |
Anticuerpos anti-pd-l1 y su uso para mejorar la funcion de celulas t.
|
|
WO2010077582A1
(en)
|
2008-12-16 |
2010-07-08 |
Merck Sharp & Dohme Corp. |
Triazole derivatives for treatment of alzheimer's disease
|
|
UY32531A
(es)
|
2009-03-31 |
2010-10-29 |
Boehringer Ingelheim Int |
Nuevos compuestos para el tratamiento de trastornos del snc
|
|
US20110045101A1
(en)
|
2009-05-06 |
2011-02-24 |
E.I. Du Pont De Nemours And Company |
Fungicidal substituted azoles
|
|
WO2010131145A1
(en)
|
2009-05-12 |
2010-11-18 |
Pfizer Limited |
Cyclobutenedione derivatives
|
|
IN2015DN02826A
(cg-RX-API-DMAC7.html)
|
2009-09-03 |
2015-09-11 |
Merck Sharp & Dohme |
|
|
WO2011029633A1
(en)
|
2009-09-14 |
2011-03-17 |
Recordati Ireland Limited |
Heterocyclic mglu5 antagonists
|
|
GB2474748B
(en)
|
2009-10-01 |
2011-10-12 |
Amira Pharmaceuticals Inc |
Polycyclic compounds as lysophosphatidic acid receptor antagonists
|
|
EP2493862B1
(en)
|
2009-10-28 |
2016-10-05 |
Newlink Genetics Corporation |
Imidazole derivatives as ido inhibitors
|
|
CA2774039A1
(en)
|
2009-11-06 |
2011-05-12 |
Aerpio Therapeutics Inc. |
Methods for increasing the stabilization of hypoxia inducible factor-1 alpha
|
|
DK2510010T3
(en)
|
2009-12-10 |
2015-12-14 |
Hoffmann La Roche |
Antibodies that bind to human CSF1R extracellular domain 4 and their use
|
|
ES2586231T3
(es)
|
2010-03-03 |
2016-10-13 |
Probiodrug Ag |
Inhibidores de glutaminil ciclasa
|
|
RU2617971C2
(ru)
|
2010-03-05 |
2017-04-28 |
Ф.Хоффманн-Ля Рош Аг |
Антитела против csf-1r человека и их применение
|
|
CN102918061B
(zh)
|
2010-03-05 |
2016-06-08 |
霍夫曼-拉罗奇有限公司 |
针对人csf-1r的抗体及其用途
|
|
SG10201502484SA
(en)
|
2010-03-30 |
2015-05-28 |
Verseon Corp |
Multisubstituted aromatic compounds as inhibitors of thrombin
|
|
EP3943154A1
(en)
|
2010-05-04 |
2022-01-26 |
Five Prime Therapeutics, Inc. |
Antibodies that bind csf1r
|
|
WO2011159633A1
(en)
|
2010-06-15 |
2011-12-22 |
Amira Pharmaceuticals, Inc. |
Inhalable formulations of lysophosphatdic acid receptor antagonists
|
|
WO2011159635A1
(en)
|
2010-06-15 |
2011-12-22 |
Amira Pharmaceuticals, Inc. |
Lysophosphatidic acid receptor antagonist for the treatment of dermal conditions
|
|
WO2011159632A1
(en)
|
2010-06-15 |
2011-12-22 |
Amira Pharmaceuticals, Inc. |
Lysophosphatidic acid receptor antagonists for the treatment of conditions or diseases of the eye
|
|
KR20120011357A
(ko)
|
2010-07-23 |
2012-02-08 |
현대약품 주식회사 |
치환된 피리디논 유도체 및 이의 제조방법
|
|
NZ729044A
(en)
|
2010-09-09 |
2020-07-31 |
Pfizer |
4-1bb binding molecules
|
|
WO2012040532A1
(en)
|
2010-09-24 |
2012-03-29 |
Bristol-Myers Squibb Company |
Substituted oxadiazole compounds and their use as s1p1 agonists
|
|
WO2012050868A1
(en)
|
2010-09-28 |
2012-04-19 |
Georgia Tech Research Corporation |
Histone deacetylase (hdac) inhibitors targeting prostate tumors and methods of making and using thereof
|
|
CN102432598A
(zh)
|
2010-09-29 |
2012-05-02 |
江苏恒瑞医药股份有限公司 |
三环化合物、其制备方法及其在医药上的应用
|
|
WO2012058531A2
(en)
|
2010-10-29 |
2012-05-03 |
North Carolina State University |
Modulation of response regulators by imidazole derivatives
|
|
WO2012078593A2
(en)
|
2010-12-07 |
2012-06-14 |
Amira Pharmaceuticals, Inc. |
Lysophosphatidic acid receptor antagonists and uses thereof
|
|
NO2694640T3
(cg-RX-API-DMAC7.html)
|
2011-04-15 |
2018-03-17 |
|
|
|
CA2833636A1
(en)
|
2011-04-20 |
2012-10-26 |
Amplimmune, Inc. |
Antibodies and other molecules that bind b7-h1 and pd-1
|
|
WO2012164085A1
(en)
|
2011-06-03 |
2012-12-06 |
Merz Pharma Gmbh & Co. Kgaa |
Glycine b antagonists
|
|
WO2013078320A1
(en)
|
2011-11-21 |
2013-05-30 |
Constellation Pharmaceuticals |
Modulators of methyl modifying enzymes, compositions and uses thereof
|
|
BR112014012819B1
(pt)
|
2011-11-28 |
2022-08-16 |
Merck Patent Gmbh |
Anticorpo anti-pd-l1 ou fragmento de ligação ao antígeno do mesmo e composição
|
|
MX356337B
(es)
|
2011-12-15 |
2018-05-23 |
Hoffmann La Roche |
Anticuerpos contra csf-1r humano y sus usos.
|
|
AR089284A1
(es)
|
2011-12-22 |
2014-08-13 |
Galapagos Nv |
Dihidropirimidinoisoquinolinonas y composiciones farmaceuticas de las mismas para el tratamiento de trastornos inflamatorios
|
|
MX2014008961A
(es)
|
2012-02-06 |
2014-10-14 |
Genentech Inc |
Composiciones y metodos para utilizar inhibidores de csf1r.
|
|
AR090263A1
(es)
|
2012-03-08 |
2014-10-29 |
Hoffmann La Roche |
Terapia combinada de anticuerpos contra el csf-1r humano y las utilizaciones de la misma
|
|
KR20150018533A
(ko)
|
2012-05-11 |
2015-02-23 |
파이브 프라임 테라퓨틱스, 인크. |
콜로니 자극 인자 1 수용체(csf1r)에 결속하는 항체들에 의한 질병 상태의 치료 방법
|
|
AR091649A1
(es)
|
2012-07-02 |
2015-02-18 |
Bristol Myers Squibb Co |
Optimizacion de anticuerpos que se fijan al gen de activacion de linfocitos 3 (lag-3) y sus usos
|
|
WO2014031928A2
(en)
|
2012-08-24 |
2014-02-27 |
Philip Jones |
Heterocyclic modulators of hif activity for treatment of disease
|
|
CN107759690A
(zh)
|
2012-08-31 |
2018-03-06 |
戊瑞治疗有限公司 |
用结合群落刺激因子1受体(csf1r)的抗体治疗病状的方法
|
|
WO2014048065A1
(en)
|
2012-09-28 |
2014-04-03 |
Merck Sharp & Dohme Corp. |
Triazolyl derivatives as syk inhibitors
|
|
AR092742A1
(es)
|
2012-10-02 |
2015-04-29 |
Intermune Inc |
Piridinonas antifibroticas
|
|
EP2922841B8
(en)
|
2012-11-08 |
2017-08-02 |
Bristol-Myers Squibb Company |
Alkyl-amide-substituted pyridyl compounds useful as modulators of il-12, il-23 and/or ifn alpha responses
|
|
HRP20220766T1
(hr)
|
2012-11-08 |
2022-09-16 |
Bristol-Myers Squibb Company |
Amidom-supstituirani heterociklički spojevi korisni kao modulatori il-12, il-23 i/ili ifn alfa odgovora
|
|
JP6293784B2
(ja)
|
2012-12-20 |
2018-03-14 |
ガラパゴス・ナムローゼ・フェンノートシャップGalapagos N.V. |
炎症性障害の治療のための新規ジヒドロピリミジノイソキノリノン及びその医薬組成物(gpr84アンタゴニスト)
|
|
JP2016507496A
(ja)
|
2012-12-21 |
2016-03-10 |
ゼニス・エピジェネティクス・コーポレイションZenith Epigenetics Corp. |
ブロモドメイン阻害剤としての新規複素環式化合物
|
|
TW201437200A
(zh)
*
|
2013-01-15 |
2014-10-01 |
Intermune Inc |
溶血磷脂酸受體拮抗劑
|
|
CA2809478A1
(en)
|
2013-03-13 |
2014-09-13 |
Queen's University At Kingston |
Luminescent compounds and methods of using same
|
|
WO2014139882A1
(en)
|
2013-03-14 |
2014-09-18 |
Galapagos Nv |
Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
|
|
WO2014179144A1
(en)
|
2013-04-29 |
2014-11-06 |
E. I. Du Pont De Nemours And Company |
Fungicidal heterocyclic compounds
|
|
CN104513213A
(zh)
|
2013-09-28 |
2015-04-15 |
山东亨利医药科技有限责任公司 |
Fxr激动剂
|
|
EP3290407B1
(en)
|
2013-10-18 |
2020-01-01 |
Celgene Quanticel Research, Inc |
Bromodomain inhibitors
|
|
ES2702126T3
(es)
|
2013-12-10 |
2019-02-27 |
Bristol Myers Squibb Co |
Compuestos de imidazopiridazina útiles como moduladores de respuestas a IL-12, IL-23 y/o IFN alfa
|
|
CN104844533B
(zh)
|
2014-02-17 |
2019-04-09 |
中国医学科学院药物研究所 |
含五元芳杂环的氨基丙二醇类化合物、其制备方法及其医药用途
|
|
US9340540B2
(en)
|
2014-02-28 |
2016-05-17 |
Nimbus Lakshmi, Inc. |
TYK2 inhibitors and uses thereof
|
|
HRP20221373T1
(hr)
|
2014-03-07 |
2023-01-06 |
Biocryst Pharmaceuticals, Inc. |
Supstituirani pirazoli kao inhibitori kalikreina u ljudskoj plazmi
|
|
WO2015162216A1
(en)
|
2014-04-24 |
2015-10-29 |
Universita' Degli Studi Di Siena |
Biaryl amide or urea derivatives as trpv1 ligands
|
|
KR20150136294A
(ko)
|
2014-05-27 |
2015-12-07 |
주식회사 레고켐 바이오사이언스 |
인자 XIa 억제 활성을 가지는 신규한 화합물
|
|
US20170114323A1
(en)
|
2014-06-19 |
2017-04-27 |
Whitehead Institute For Biomedical Research |
Uses of kinase inhibitors for inducing and maintaining pluripotency
|
|
GB201411241D0
(en)
|
2014-06-25 |
2014-08-06 |
Galapagos Nv |
Novel dihydropyridoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disorders
|
|
WO2016014674A1
(en)
|
2014-07-22 |
2016-01-28 |
University Of Maryland, College Park |
Linked diaryl compounds with anticancer properties and methods of using the same
|
|
KR102160489B1
(ko)
|
2014-07-25 |
2020-09-29 |
삼성디스플레이 주식회사 |
표시 장치의 제조 방법 및 표시 장치
|
|
DE102014115154A1
(de)
|
2014-10-17 |
2016-04-21 |
SCV-SpezialChemikalien-Vertrieb GmbH |
Konjugierte Bisphosphonate für die Diagnostik und Therapie von Knochenerkrankungen
|
|
WO2016139227A1
(en)
|
2015-03-03 |
2016-09-09 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Fgfr3 antagonists
|
|
CN104876912B
(zh)
|
2015-04-08 |
2017-07-21 |
苏州云轩医药科技有限公司 |
Wnt信号通路抑制剂及其应用
|
|
GB201506894D0
(en)
|
2015-04-23 |
2015-06-10 |
Galapagos Nv |
Novel dihydropyridoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disorders
|
|
CN106316975A
(zh)
|
2015-06-15 |
2017-01-11 |
山东轩竹医药科技有限公司 |
酰胺类化合物及其作为tgr5激动剂的应用
|
|
KR101666759B1
(ko)
|
2015-08-06 |
2016-10-18 |
경북대학교 산학협력단 |
1-벤조피란메틸-1h-1,2,3-트리아졸 유도체 및 이의 용도
|
|
US20170066778A1
(en)
|
2015-09-04 |
2017-03-09 |
Aunova Medchem LLC |
Solubility for target compounds
|
|
CA2988391C
(en)
|
2015-10-19 |
2023-05-09 |
Latvian Institute Of Organic Synthesis |
Substituted aminoalkylazoles as malarial aspartic protease inhibitors
|
|
CN106632082B
(zh)
|
2015-11-04 |
2020-10-09 |
中国科学院上海药物研究所 |
一类对gpr84具有激动作用的化合物及其制备方法和用途
|
|
JP2019509980A
(ja)
|
2016-01-29 |
2019-04-11 |
バイオベンチャーズ・リミテッド・ライアビリティ・カンパニーBioVentures, LLC |
メランポマグノリドbのトリアゾール誘導体及びその使用方法
|
|
MX2018014929A
(es)
|
2016-06-02 |
2019-08-26 |
Sanofi Sa |
Conjugados de un agente farmaceutico y una porcion capaz de unirse a una proteina sensora de glucosa.
|
|
KR20230156818A
(ko)
|
2016-10-03 |
2023-11-14 |
시질론 테라퓨틱스, 인크. |
화합물, 장치, 및 이의 용도
|
|
US11358940B2
(en)
|
2017-04-20 |
2022-06-14 |
The Regents Of The University Of California |
K-Ras modulators
|
|
EP3621962A4
(en)
|
2017-05-10 |
2020-12-09 |
Forge Therapeutics, Inc. |
ANTIBACTERIAL COMPOUNDS
|
|
EP3403649A1
(en)
|
2017-05-16 |
2018-11-21 |
Bayer Pharma Aktiengesellschaft |
Inhibitors and antagonists of gpr84 for the treatment of endometriosis
|
|
WO2018227228A1
(en)
|
2017-06-13 |
2018-12-20 |
Commonwealth Scientific And Industrial Research Organisation |
Antiviral drugs
|
|
WO2019060693A1
(en)
*
|
2017-09-22 |
2019-03-28 |
Kymera Therapeutics, Inc. |
CRBN LIGANDS AND USES THEREOF
|
|
US11267811B2
(en)
*
|
2017-09-27 |
2022-03-08 |
Bristol-Myers Squibb Company |
Small molecule inhibitors of galectin-3
|
|
US10336724B2
(en)
|
2017-10-18 |
2019-07-02 |
Syneurx International (Taiwan) Corp. |
D-amino acid oxidase inhibitors and therapeutic uses thereof
|
|
US11753400B2
(en)
|
2017-10-18 |
2023-09-12 |
Syneurx International (Taiwan) Corp. |
D-amino acid oxidase inhibitors and therapeutic uses thereof
|
|
US20210106582A1
(en)
|
2017-11-15 |
2021-04-15 |
Galapagos Nv |
Compounds and pharmaceutical compositions thereof for use in the treatment of fibrotic diseases
|
|
WO2019165158A1
(en)
|
2018-02-22 |
2019-08-29 |
University Of Florida Research Foundation, Incorporated |
Il-6 inhibitors and methods of treatment
|
|
CN110396089A
(zh)
|
2018-04-24 |
2019-11-01 |
杭州健昵福生物科技有限公司 |
靶向肾型谷氨酰胺酶变构位点的化合物及应用
|
|
IL260273A
(en)
|
2018-06-26 |
2018-07-31 |
Shabat Matan |
Epidural device
|
|
UY38291A
(es)
|
2018-07-05 |
2020-06-30 |
Servier Lab |
Nuevos derivados de amino-pirimidonilo un proceso para su preparación y composiciones farmacéuticas
|
|
WO2020006724A1
(zh)
|
2018-07-05 |
2020-01-09 |
清华大学 |
一种靶向降解fak蛋白的化合物及其应用
|
|
EP3594205A1
(en)
|
2018-07-09 |
2020-01-15 |
Abivax |
Phenyl-n-aryl derivatives for treating a rna virus infection
|
|
KR102131022B1
(ko)
|
2018-07-12 |
2020-07-07 |
보령제약 주식회사 |
피리미디논 유도체 화합물 및 이의 용도
|
|
JP7547314B2
(ja)
|
2018-07-24 |
2024-09-09 |
エフ. ホフマン-ラ ロシュ アーゲー |
質量分析のための試薬
|
|
AU2019312296B2
(en)
|
2018-07-27 |
2025-05-29 |
Arcus Biosciences, Inc. |
Pyridone A2R antagonists
|
|
US11945803B2
(en)
|
2018-08-07 |
2024-04-02 |
Tosk, Inc. |
Modulators of RAS GTPase
|
|
WO2020055164A1
(ko)
|
2018-09-12 |
2020-03-19 |
크리스탈지노믹스(주) |
7-하이드록시-4h-티에노[3,2-b]피리딘-5-온 유도체 및 그의 용도
|
|
CN109456250B
(zh)
|
2018-11-08 |
2022-03-04 |
哈尔滨医科大学 |
热激活延迟荧光(tadf)纳米探针及其制备方法和在生物成像中的应用
|
|
JP7594787B2
(ja)
|
2018-12-07 |
2024-12-05 |
ユニバーシティ オブ メリーランド、ボルチモア |
非ATP/触媒部位p38マイトジェン活性化プロテインキナーゼ阻害剤
|
|
CN109369623B
(zh)
|
2018-12-14 |
2020-04-21 |
山东大学 |
一种取代1,2,3三氮唑类二芳基嘧啶衍生物及其制备方法与应用
|
|
MX2021007382A
(es)
|
2018-12-18 |
2021-07-15 |
Merck Sharp & Dohme Llc |
Derivados de pirimidona como agentes citotoxicos selectivos contra celulas infectadas por vih.
|
|
US11795160B2
(en)
|
2019-02-22 |
2023-10-24 |
Insilico Medicine Ip Limited |
Kinase inhibitors
|
|
WO2021123394A1
(en)
|
2019-12-20 |
2021-06-24 |
University Of Copenhagen |
G protein-coupled receptor modulators and a pharmaceutical composition
|
|
KR20230153387A
(ko)
|
2021-02-02 |
2023-11-06 |
리미널 바이오사이언시스 리미티드 |
Gpr84 길항제 및 이의 용도
|